17 Recruiting Studies Using Axatilimab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Axatilimab
Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
📍 Karmanos Cancer Institute — Detroit, Michigan
Hodgkin Lymphoma
View Study & Checklist ➔MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
📍 Royal Prince Alfred Hospital — Camperdown, New South Wales
Idiopathic Pulmonary Fibrosis
View Study & Checklist ➔A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
📍 Mayo Clinic Hospital — Phoenix, Arizona
Chronic Graft-versus-host-disease
View Study & Checklist ➔Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML
📍 Northside Hospital, Inc. — Atlanta, Georgia
Acute Myeloid Leukemia
View Study & Checklist ➔Axatilimab + CAR-T for High-Risk Lymphoma
📍 Northside Hospital — Atlanta, Georgia
Diffuse Large B Cell Lymphoma (DLBCL)
View Study & Checklist ➔ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation
📍 Cedars-Sinai Medical Center — Los Angeles, California
TNBC - Triple-Negative Breast Cancer
View Study & Checklist ➔Effects of Axatilimab on Skin in Chronic Graft-versus-Host Disease
📍 Northwestern Medicine — Chicago, Illinois
Chronic Graft vs. Host Disease
View Study & Checklist ➔Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
Hematopoietic and Lymphatic System Neoplasm
View Study & Checklist ➔Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
📍 Cedars-Sinai Medical Center — Los Angeles, California
TNBC - Triple-Negative Breast Cancer
View Study & Checklist ➔Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
📍 University of California, San Francisco — San Francisco, California
Chronic Graft Versus Host Disease
View Study & Checklist ➔A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
📍 University of Alabama at Birmingham - Children's of Alabama — Birmingham, Alabama
Chronic Graft-versus-host-disease
View Study & Checklist ➔Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Atypical Chronic Myeloid Leukemia
View Study & Checklist ➔A Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to Potentiate Axatilimab (A) + Retifanlimab (R) in Treating Metastatic Triple Negative Breast Cancer (TNBC)
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
Breast Cancer
View Study & Checklist ➔Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors
📍 OHSU Knight Cancer Institute — Portland, Oregon
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
📍 Moffitt Cancer Center — Tampa, Florida
Chronic Graft Versus Host Disease
View Study & Checklist ➔Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
Myelofibrosis (MF)
View Study & Checklist ➔Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
Breast Cancer
View Study & Checklist ➔